Syndicate This week's upcoming IPO's and secondary offerings

Week of October 26 to October 30, 2024

This Week's Deals to be Priced

10/28 - Wednesday

Symbol

Issuer

Type

Price

Managers

AHM

AmeriHome Mortgage
AmeriHome Mortgage
IPO
Postponed $16.00-18.00
14.705M
Credit Suisse,...

Pricing after close
Deal analysis and details

Managers: Credit Suisse, Goldman Sachs, JPMorgan, Wells Fargo, Barclays, BofA, Citi, RBC Capital & UBS, Apollo Global, Houlihan Lokey, Seibert Williams

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
HOMS

Caliber Home Loans
Caliber Home Loans
IPO
Postponed $14.00-16.00
23M
Credit Suisse,...

Pricing after close
Deal analysis and details

Managers: Credit Suisse, Goldman Sachs & Barclays, BofA, Citi, UBS, Wells Fargo, Deutsche Bank, Keefe Bruyette, DREX, Loop Capital, R. Seelaus, Tigress Financial

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MVNR

Mavenir Systems
Mavenir Systems
IPO
Postponed $20.00-24.00
12.5M
Morgan Stanley,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Morgan Stanley, Goldman Sachs, JPMorgan & BofA, Barclays, Guggenheim, Macquarie, Needham

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/29 - Thursday

Symbol

Issuer

Type

Price

Managers

GOSS

Gossamer Bio
Gossamer Bio
Block Trade
$7.95-8.60
1.9M
Goldman Sachs

Pricing after close

Managers: Goldman Sachs

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
OBSV

ObsEva
ObsEva
Block Trade
$1.95-2.00
1.1M
Morgan Stanley

Pricing after close

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GMVD

G Medical Innovations
G Medical Innovations
IPO
$5.00-7.00
5M
Boustead & Fosun

Pricing after close

Managers: Boustead & Fosun

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

This Week's Priced Deals

10/26 - Monday

Symbol

Issuer

Type

Price

Managers

TPTX

Turning Point Therapeutics
Turning Point Therapeutics
Secondary
Priced: $87.00
4.598M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, SVB Leerink & Guggenheim, Wedbush, Roth Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/27 - Tuesday

Symbol

Issuer

Type

Price

Managers

MC

Moelis
Moelis
Block Trade
Priced: $38.75
1.83M
Morgan Stanley

Pricing after close
Deal analysis and details

Managers: Morgan Stanley

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
BDSX

Biodesix
Biodesix
IPO
Priced: $18.00
4M
Morgan Stanley & William Blair,...

Pricing after close
Deal analysis and details

Managers: Morgan Stanley & William Blair, Canaccord, BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GATO

Gatos Silver
Gatos Silver
IPO
Priced: $7.00
21.43M
BMO Capital,...

Pricing after close
Deal analysis and details

Managers: BMO Capital, Goldman Sachs & RBC Capital, Canaccord, CIBC

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
IKT

Inhibikase Therapeutics
Inhibikase Therapeutics
IPO
Priced: $10.00
1.36M
ThinkEquity

Pricing after close
Deal analysis and details

Managers: ThinkEquity

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MAX

MediaAlpha
MediaAlpha
IPO
Priced: $19.00
9.25M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Citi, Credit Suisse, RBC Capital, Canaccord & William Blair, MUFG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ROOT

Root
Root
IPO
Priced: $27.00
26.831M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, Morgan Stanley, Barclays & Wells Fargo, Deutsche Bank, Truist, Citi, Credit Suisse, Evercore ISI, UBSS, Cantor Fitzgerald, JSSF, SIEB, HUNT

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
MRTX

Mirati Therapeutics
Mirati Therapeutics
Secondary
Priced: $202.00
4.33M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Managers: Goldman Sachs, SVB Leerink, Cowen & Evercore ISI

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
EQT

EQT Corporation
EQT Corporation
Spot Secondary
Priced: $15.50
20M
Citi,...

Pricing after close
Deal analysis and details

Managers: Citi, Credit Suisse, BofA & Barclays

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/28 - Wednesday

Symbol

Issuer

Type

Price

Managers

ALGM

Allegro MicroSystems
Allegro MicroSystems
IPO
Priced: $14.00
25M
Barclays,...

Pricing after close
Deal analysis and details

Managers: Barclays, Credit Suisse, Wells Fargo, Jefferies, Mizuho, Needham & SMBC Nikko

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GLTO

Galecto
Galecto
IPO
Priced: $15.00
5.667M
BofA,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: BofA, SVB Leerink & Credit Suisse, KEMP

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LESL

Leslie's
Leslie's
IPO
Priced: $17.00
40M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, Morgan Stanley & BofA, Jefferies, Nomura, Baird, Guggenheim, Piper Sandler, William Blair, TSLY, Loop Capital, RMRZ, AVET

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
ALLK

Allakos
Allakos
Secondary
Priced: $82.00
3.05M
Jefferies,...

Pricing after close
Deal analysis and details

Managers: Jefferies, BofA & SVB Leerink, LifeSci Capital, William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
RARE

Ultragenyx
Ultragenyx
Secondary
Priced: $90.00
4.44M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Goldman Sachs, BofA & Cowen

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
FBRX

Forte Biosciences
Forte Biosciences
Spot Secondary
Priced: $28.50
1.404M
Ladenburg,...

Pricing after close
Deal analysis and details

Managers: Ladenburg, Truist & Chardan, Brookline

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SRRK

Scholar Rock
Scholar Rock
Spot Secondary
Priced: $39.00
2.949M
JPMorgan,...

Pricing after close
Deal analysis and details

Managers: JPMorgan, Jefferies & Credit Suisse, BMO Capital

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

10/29 - Thursday

Symbol

Issuer

Type

Price

Managers

AVIR

Atea Pharmaceuticals
Atea Pharmaceuticals
IPO
Priced: $24.00
12.5M
JPMorgan,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: JPMorgan, Morgan Stanley, Evercore ISI & William Blair

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
LU

Lufax
Lufax
IPO
Priced: $13.50
175M
Goldman Sachs,...

Pricing after close
Deal analysis and details

Unlock Ratings
Log in above or sign up for a free trial to get the rating on this deal.
Get Free Trial

Managers: Goldman Sachs, BofA, UBS & HSBC, China PA, Morgan Stanley, CLSA, Jefferies, JPMorgan, BOCI, Haitong, Stifel, CHRC, KeyBanc

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
SQZ

SQZ Biotechnologies
SQZ Biotechnologies
IPO
Priced: $16.00
4.412M
BofA,...

Pricing after close
Deal analysis and details

Managers: BofA, Evercore ISI & Stifel, BTIG

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account
GLPI

Gaming and Leisure Properties
Gaming and Leisure Properties
Spot Secondary
Priced: $36.25
8M
Wells Fargo,...

Pricing after close
Deal analysis and details

Managers: Wells Fargo, BofA, Barclays & Mizuho

Exclusive Analysis Locked
Proprietary deal commentary available to members only. Sign up or login for access.
Create FREE Account

Get Full Fly Access